Adherence to HAART among patients with HIV: Breakthroughs and barriers

AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV

Volumn 14, Issue 3, 2002, Pages 309-318

  Ickovics, Jeannette R ^a   Meade, C S ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

CLINICAL PRACTICE; CONFERENCE PAPER; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PATIENT COMPLIANCE; PRIORITY JOURNAL; SOCIAL PSYCHOLOGY; TREATMENT OUTCOME;

ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; HIV INFECTIONS; HUMANS; PATIENT COMPLIANCE; RISK FACTORS;

EID: 0036270576     PISSN: 09540121     EISSN: None     Source Type: Journal    
DOI: 10.1080/09540120220123685     Document Type: Conference Paper

References (70)

1. Trust and acceptance of and adherence to antiretroviral therapy
2. Intervention trial using a novel electronic devide in HAART initiators: Impact of cognitive dysfunction
3. Helping the urban poor stay with antiretroviral HIV drug therapy: Action point services include counseling, medication, cash incentives, and even e-mail reminders
4. Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population
5. Non-adherence to highly active antiretroviral therapy predicts progression to AIDS
6. Randomized placebo-controlled trial of ritonavir in advanced HIV-1 disease
7. Antiretroviral therapy in adults: Updated recommendations of the International AIDS Society-USA Panel
8. Patterns, correlates and barriers to medication adherence among persons prescribed new treatments for HIV disease
9. Factors affecting adherence to antiretroviral therapy
10. Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: The AACTG adherence instruments
11. Adherence in chronic disease
12. Adherence to antiretroviral and pneumocystis prophylaxis in HIV disease
13. Adherence to pharmacological interventions: Current trends and future directions
14. Compliance with AZT treatment regimen of HIV-seropositive injection drug users: A neglected issue
15. Adherence to antiretroviral regimens in HIV-infected patients: Results of a survey among physicians and patients
16. The relationship of disease severity, health beliefs and medication adherence among HIV patients
17. Predictors of self-reported adherence and plasma HIV concentrations in patients on multidrug antiretroviral regimens
18. Sociodemographic and psychological variables influencing adherence to antiretroviral therapy
19. Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy
20. Meta-analysis of correlates of provider behavior in medical encounters
21. A controlled trial of two nucleoside analogs plus indinavir in persons with human immunodeficiency virus infections and CD4 cell counts of 200 per cubic millimeter or less
22. Doctor-patient interaction, patients' health behavior and effects of treatment
23. Antiretroviral drug resistance testing in adults with HIV infection
24. Adherence in AIDS clinical trials: A framework for clinical research and clinical care
25. Determinants of heterogeneous adherence to HIV-antiretroviral therapies in the multicenter AIDS cohort study
26. Adherence and effectiveness of highly active antiretroviral therapy
27. Adherence to highly active antiretroviral treatment: Impact on individualized assessment
28. Highly active antiretroviral therapy in a large urban clinic: Risk factors for virologic failure and adverse drug reactions
29. Management of the adverse effects of antiretroviral therapy and medication adherence
30. Enhancing adherence to combination antiretroviral therapy in non-adherent HIV-positive men
31. A randomized double-blind trial comparing combinations of nevaripine, didanosine, and zidovudine for HIV-infected patients: The INCAS trial
32. Determinants of subject compliance within an experimental anti-HIV drug protocol
33. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection
34. Adherence to protease inhibitor therapy and outcomes in patients with HIV infections
35. Measuring adherence to asthma medication regimens
36. Cue-dose training with monetary reinforcement: Pilot study of an antiretroviral adherence intervention
37. Barriers to antiretroviral medication adherence in HIV-infected women
38. The magnitudes of compliance and noncompliance
39. Compliance with zidovudine therapy in patients infected with human immunodeficiency virus, type 1: A cross-sectional study in a municipal hospital clinic
40. Measuring adherence among HIV infected persons: Is MEMS consummate technology?
41. Determinants of compliance with antiretroviral therapy in patients with human immunodeficiency virus: Prospective assessment with implications for enhancing compliance
42. Adherence to highly active antiretroviral therapies (HAART) in HIV-infected patients: From a predictive to a dynamic approach
43. Adherence to antiretroviral therapy among HIV-infected methadone patients: Effects of ongoing illicit drug use
44. HIV/AIDS patients' perspectives on adhering to regimens containing protease inhibitors
45. Prospective randomized two-arm controlled study to determine the efficacy of a specific intervention to improve long-term adherence to highly active antiretroviral therapy
46. Human immunodeficiency virus 1 protease inhibitors in clinical practice: Predictors of virological outcome
47. Public health implications of antiretroviral therapy and HIV drug resistance
48. Adherence to zidovudine (AZT) among HIV-infected methadone patients: A pilot study of supervised therapy and dispensing compared to usual care
49. Adherence to antiretroviral medications in an inner-city population